Alpha-blocker therapy does not decrease the risk for prostate cancer death, but it is associated with an elevated risk for low-grade prostate cancer. Preclinical studies have suggested that ...

The FDA has notified healthcare professionals that the Boxed Warning for the tumor necrosis factor-alpha (TNF-alpha) blocker class of drugs has been updated to include the risk of infection from ...

New findings could allow clinicians to have more nuanced discussions with patients who have chronic kidney disease regarding the long-term risks associated with alpha blocker use to control blood ...

Please provide your email address to receive an email when new articles are posted on . Patients taking alpha blockers had no significant increased risk for fractures after 2 years. Alpha blocker use ...

A systematic review evaluated the efficacy of calcium channel blockers or alpha blockers for the treatment of urinary stones in nine randomized trials with 693 patients (Lancet. 2006;368:1171-1179).